Global Breast Imaging Technologies Market

Breast Imaging Technologies Market Size, Share, Growth Analysis, By Type of Imaging Technique(Mammography, Breast Ultrasound, Breast MRI, Image-Guided Breast Biopsy), By End-User(Hospitals, Diagnostic Centers, Others), By Type of Imaging Technique(Ionizing Breast Imaging (Mammography {Full-field digital mammography, 3D breast tomosynthesis, analog mammography}, Positron Emission Tomography-computed tomography) - Industry Forecast 2024-2031

Report ID: SQMIG35G2234 | Region: Global | Published Date: February, 2024
Pages: 260 | Tables: 102 | Figures: 77

Breast Imaging Technologies Market News

  • In April 2022, DetectedX and GE Healthcare announced an educational partnership to enhance access to DetectedX's Radiology Online Learning Platform, with the goal of fostering global excellence in diagnostic accuracy. The online self-assessment modules, designed to increase radiologists' ability to correctly diagnose breast lesions in 2D and 3D mammography, have been proven to cut recall rates and improve cancer detection by more than 34%.
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.



Breast Imaging Technologies Market size was valued at USD 4.33 billion in 2019 and is poised to grow from USD 4.7 billion in 2023 to USD 9 billion by 2031, growing at a CAGR of 8.6% in the forecast period (2024-2031).

The market is fragmented in nature. The prominent players operating in the market are constantly adopting various growth strategies in order to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. The key market players are also constantly focused on R&D in order to supply industries with the most efficient and cost-effective solutions. 'Hologic, Inc.', 'Siemens Healthineers', 'Allengers', 'GE Healthcare', 'Fujifilm Holdings Corporation', 'Philips Healthcare', 'Toshiba Medical Systems Corporation', 'Carestream Health, Inc.', 'Aurora Imaging Technology, Inc.', 'Dilon Technologies Inc.', 'Planmed Oy', 'CMR Naviscan Corporation', 'Metaltronica S.p.A', 'SonoCiné, Inc.', 'Micrima Limited', 'SuperSonic Imagine', 'iCAD, Inc.', 'Gamma Medica, Inc.', 'Planmeca Group', 'Delphinus Medical Technologies, Inc.', 'Siemens AG'

The key factor that drives the industry growth includes the rising prevalence of breast cancer among women and increased demand for the early diagnosis and treatment of breast cancer. For instance, according to, approximately 281,550 new invasive breast cancer cases were detected in women in the United States in 2021. Furthermore, according to the same source, 1 in every 8 US women develops invasive breast cancer during her lifetime. Hence, an increase in the prevalence of breast cancer is likely to encourage the adoption of breast imaging technologies for the early diagnosis and treatment of breast cancer.

One of the key trends in the breast imaging technologies market is the integration of advanced technologies such as artificial intelligence with breast imaging techniques. Artificial intelligence aids in the optimization of workflows for faster and more accurate detection. Radiologists can find more malignancies using artificial intelligence instead of analyzing a big amount of 3D screening data. The use of artificial intelligence in breast imaging is gaining traction around the world.

The Breast Imaging Technologies Market is segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. In 2022, the Asia-Pacific region is projected to hold the most substantial share of the market. The regional market is likely to be driven by the rising prevalence of breast cancer, rising healthcare spending, an increase in the number of breast cancer awareness initiatives, and significant government spending on breast cancer research studies in the emerging economies of the region such as China and India. According to GLOBOCAN 2018, Asia recorded a total of 911,014 new breast cancer cases in 2018, which is anticipated to increase to 229,650 by the end of 2030. Such increased prevalence of breast cancer cases is likely to encourage the adoption of various breast imaging technologies and hence contribute to the growth of the market during the forecast period.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.


Feedback From Our Clients

Global Breast Imaging Technologies Market

Product ID: SQMIG35G2234